Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Hong-Li Xi"'
Publikováno v:
Chinese Medical Journal, Vol 129, Iss 8, Pp 929-935 (2016)
Background: The ultimate goal of hepatitis B treatment is hepatitis B surface antigen (HBsAg) seroclearance. Several factors have been suggested to be associated with the rate of HBsAg reduction in antiviral-naive or lamivudine therapy cohorts. Howev
Externí odkaz:
https://doaj.org/article/6a3f6851b7e849e4b61abb8ab560468a
Autor:
Min-Ran Li, Hong-Li Xi, Qin-Huan Wang, Feng-Qin Hou, Na Huo, Xia-Xia Zhang, Fang Li, Xiao-Yuan Xu
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98476 (2014)
BACKGROUND & AIMS: About 350-400 million people are infected with hepatitis B virus (HBV) chronically and 1 million people die of hepatitis B virus (HBV)-related liver diseases. Nucleos(t)ide analogues (NAs) have been used for the treatment against H
Externí odkaz:
https://doaj.org/article/d1a169145b2e46e6b15abbc8aae0191e
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89291 (2014)
BACKGROUND: Natural drug resistance is a major cause of antiviral treatment failure. The characteristics of HIV-1 natural drug resistance-associated mutations in former paid blood donors in Henan Province remain unclear. METHODS: One hundred and fift
Externí odkaz:
https://doaj.org/article/c62be166771644a3a9c04f3e02feda93
Autor:
Ning Tan, Ran Cheng, Qian Kang, Yu-Ping Yang, Jiali Pan, Hong-Li Xi, Xiaoyuan Xu, Hongyu Chen, Hao Luo, Yifan Han
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Hepatitis B surface antigen (HBsAg) loss, a functional cure in patients with chronic hepatitis B (CHB) undergoing antiviral therapy, might be an ideal endpoint of antiviral treatment in clinical practice. The factors that contribute to the
Autor:
Jing-Hang Xu, Dan Liu, Yifan Han, Xiaoyuan Xu, Hongyu Chen, Qian Kang, Yuqing Yang, Jiali Pan, Min Yu, Hao Luo, Ning Tan, Ran Cheng, Hong-Li Xi
Publikováno v:
Journal of Viral Hepatitis. 28:1284-1292
Limited data are currently available regarding fibrosis progression after hepatitis C virus (HCV) eradication. The goal of the present study was to evaluate the effects of HCV eradication on liver stiffness measurements (LSMs), aspartate aminotransfe
Publikováno v:
Journal of Viral Hepatitis. 27:323-328
We examined whether the hepatitis B virus (HBV) pregenomic RNA (pgRNA) status after nucleos(t)ide (NA) treatment can predict the long-time prognoses of chronic hepatitis B patients. Patients with chronic hepatitis B (98) who were treatment-naive and
Publikováno v:
Journal of Mechanics in Medicine and Biology. 21
Objective: To analyze the correlation between the vascular endothelial function (characterized by endothelin-1 and nitric oxide) and the renal hemodynamics in patients with hypertensive disorders in pregnancy (HDP) by color Doppler ultrasound. Method
Publikováno v:
Aging (Albany NY)
In recent years, a growing body of evidence has provided support for the important role of microRNAs (miRNAs) in the progression of human cancers. A recent study showed that a novel miRNA miR-3650 expression was significantly decreased in hepatocellu
Publikováno v:
World Journal of Gastroenterology
BACKGROUND Characteristics of alterations of serum hepatitis B virus (HBV) RNA in different chronic hepatitis B (CHB) patients still cannot be fully explained. Whether HBV RNA can predict HBeAg seroconversion is still controversial. AIM To investigat
Autor:
Xia-Xia Zhang, Min Yu, Xiaoyuan Xu, Qian Kang, Ning Tan, Yifan Han, Dan Liu, Hui Gao, Yaoyu An, Jianhong Chen, Hao Luo, Ran Cheng, Hong-Li Xi
Publikováno v:
Disease Markers
Disease Markers, Vol 2020 (2020)
Disease Markers, Vol 2020 (2020)
Aim. The success of direct-acting antivirals (DAAs) against hepatitis C virus is a major breakthrough in hepatology. Previous studies have shown that chitinase 3-like protein 1 (CHI3L1) was a marker for staging of liver fibrosis caused by HCV. In thi